Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-105838
Filing Date
2016-03-03
Accepted
2016-03-03 20:58:52
Documents
2
Period of Report
2016-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5661
2 POA DOCUMENT poa.txt EX-24.4_640128 4063
  Complete submission text file 0001209191-16-105838.txt   11341
Mailing Address C?O GUILFORD PHARMACEUTICALS INC 6611 TRIBUTARY STREET BALTIMORE MD 21224
Business Address
Spengler William (Reporting) CIK: 0001297399 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36326 | Film No.: 161483423

Mailing Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000
Business Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000 353-1-268-2000
Endo International plc (Issuer) CIK: 0001593034 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations